CCP Cancer UK Study. Companion study to educate and inform practice and guidelines regarding COVID-19 infection in cancer patients
Not Applicable
Completed
- Conditions
- Cancer, COVID-19 (SARS-CoV-2 infection)Cancer
- Registration Number
- ISRCTN15019599
- Lead Sponsor
- Clatterbridge Cancer Centre NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Patients with proven COVID-19 and a diagnosis of cancer who are enrolled into any tier of the Principal CCP-UK protocol
Exclusion Criteria
None in addition to those specified in the Principal CCP-UK protocol:
Exclusion criteria specified in CCP-UK Protocol:
1. Confirmed diagnosis of a pathogen unrelated to the objectives of this study and no indication or likelihood of co-infection with a relevant pathogen
2. Refusal by participant, parent or appropriate representative
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure as of 30/04/2024:<br>Measured at the end of the study:<br>1. Determine the mortality rate in patients with cancer and COVID-19, using data from the CCP-UK study and linked data<br>2. Identify factors associated with the poor outcomes in patients with cancer and COVID-19, using data from the CCP-UK study and linked data<br><br><br><br>Previous primary outcome measure:<br>Measured at the end of the study:<br>1. Mortality rate in patients with cancer and COVID-19, using data from the CCP-UK study and linked data <br>2. Factors associated with the poor outcomes in patients with cancer and COVID-19, using data from the CCP-UK study and linked data
- Secondary Outcome Measures
Name Time Method